Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleThe premium of a big pharma license deal.AuthorsO'Connell, Kara E; Frei, Patrik; Dev, Kumlesh KAbstractA letter to the editor is presented related to the drug license deal of several pharmaceutical companies including Novartis, GlaxoSmithKline and Pfizer.SubjectsNOVARTIS AG; GLAXOSMITHKLINE; PFIZER Inc.PublicationNature Biotechnology, 2014, Vol 32, Issue 7, p617ISSN1087-0156Publication typeArticleDOI10.1038/nbt.2946